跳至主要内容
临床试验/NCT03923400
NCT03923400已完成不适用

Characteristics and Prognosis of Jejunoileal Gastrointestinal Stromal Tumors (GISTs) in the Era of Imatinib. A Comparative Retrospective Study With Gastric GISTs.

Hospital Universitario Virgen de la Arrixaca1 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2016年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
77
试验地点
1
主要终点
Expression of DOG1

研究概览

简要总结

Introduction: Gastrointestinal Stromal Tumors (GISTs) located in the jejunum or ileum (JI-GIST) are considered of worse prognosis compared to other locations. It has been suggested that this dogma should be revised. The aim of this study is to describe the characteristics of jejunoileal GISTs and its prognosis; and to compare them with gastric GISTs in the era of imatinib.

Patients and methods: We retrospectively reviewed the clinical histories of all the patients diagnosed with GISTs between January 2000 and November 2016. Clinical and pathological data, as well recurrence, metastatic, disease-free survival (DFS) as overall (OS) rates of patients with JI-GIST or gastric GIST (G-GIST) were collected and compared.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Any kind of primary mesenchymal tumor of the gastrointestinal tract with a histomorphological and immunohistochemical (CD117 (+) and/or DOG1 (+)) profile consistent with GIST.

排除标准

  • 未提供

结局指标

主要结局

Expression of DOG1

时间窗: 15 years

Number of patients with immunohistochemical expression of DOG1

Deceased

时间窗: 15 years

Number of patients deceased during follow-up.

KIT Gene mutation

时间窗: 15 years

Number of patients with a molecular analysis positive for KIT mutation

Expression of CD117

时间窗: 15 years

Number of patients with immunohistochemical expression of CD117

Location

时间窗: 15 years

Location of the tumor (gastric o jejunoileal)

PDGFRA Gene mutation

时间窗: 15 years

Number of patients with a molecular analysis positive for PDGFRA mutation

Recurrence

时间窗: 15 years

Number of patients with recurrence after treatment with tyrosinkin inhibitors.

次要结局

未报告次要终点

研究者

发起方
Hospital Universitario Virgen de la Arrixaca
申办方类型
Other
责任方
Principal Investigator
主要研究者

David Ferreras

Principal Investigator

Hospital Universitario Virgen de la Arrixaca

研究点 (1)

Loading locations...

相似试验